News

Torrent Pharmaceuticals announced that the 53th Annual General Meeting(AGM) of the company will be held on 23 June 2026.

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 9 per equity Share (i.e. 180%) , subject to the approval of the shareholders.

Net profit of Torrent Pharmaceuticals declined 26.91% to Rs 364.00 crore in the quarter ended March 2026 as against Rs 498.00 crore during the previous quarter ended March 2025. Sales rose 41.90% to Rs 4128.00 crore in the quarter ended March 2026 as against Rs 2909.00 crore during the previous quarter ended March 2025.For the full year,net profit rose 11.88% to Rs 2138.00 crore in the year ended March 2026 as against Rs 1911.00 crore during the previous year ended March 2025. Sales rose 21.53% to Rs 13753.00 crore in the year ended March 2026 as against Rs 11317.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales4128.002909.00 42 13753.0011317.00 22 OPM %32.8533.14 -33.1532.88 - PBDT1103.00890.00 24 4080.003492.00 17 PBT595.00689.00 -14 2961.002697.00 10 NP364.00498.00 -27 2138.001911.00 12 Powered by Capital Market - Live News

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Torrent Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 28 April 2026.Powered by Capital Market - Live News